Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
Japan · Delayed Price · Currency is JPY 279.00
-2.00 (-0.71%)
May 29, 2026, 3:30 PM JST
Wakamoto Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
| 9,707 | 8,595 | 8,877 | 11,246 | 13,395 | 13,622 | |
Market Cap Growth | -15.20% | -3.18% | -21.07% | -16.05% | -1.66% | -60.29% |
Enterprise Value | - | 8,754 | 8,826 | 11,222 | 10,898 | 9,982 |
Last Close Price | 279.00 | 223.77 | 231.02 | 290.55 | 340.55 | 341.26 |
PE Ratio | - | - | - | 231.79 | 38.12 | 33.48 |
PS Ratio | 1.03 | 0.91 | 0.92 | 1.15 | 1.33 | 1.34 |
PB Ratio | 0.80 | 0.71 | 0.73 | 0.89 | 1.05 | 1.06 |
P/TBV Ratio | 0.83 | 0.74 | 0.74 | 0.90 | 1.06 | 1.07 |
P/FCF Ratio | 49.03 | 43.41 | - | - | - | 54.74 |
P/OCF Ratio | 16.48 | 14.59 | 25.66 | 22.98 | 16.25 | 15.23 |
EV/Sales Ratio | - | 0.93 | 0.91 | 1.15 | 1.08 | 0.98 |
EV/EBITDA Ratio | - | 17.23 | 19.70 | 16.10 | 14.40 | 8.89 |
EV/EBIT Ratio | - | - | - | - | 53.55 | 16.36 |
EV/FCF Ratio | - | 44.21 | - | - | - | 40.11 |
Debt / Equity Ratio | 0.14 | 0.14 | 0.12 | 0.13 | 0.00 | - |
Debt / EBITDA Ratio | 3.26 | 3.26 | 3.28 | 2.37 | 0.04 | - |
Debt / FCF Ratio | 8.37 | 8.37 | - | - | - | - |
Net Debt / Equity Ratio | -0.02 | -0.02 | -0.01 | -0.02 | -0.19 | -0.29 |
Net Debt / EBITDA Ratio | -0.42 | -0.42 | -0.35 | -0.43 | -3.22 | -3.35 |
Net Debt / FCF Ratio | -1.07 | -1.07 | 1.29 | 0.14 | 2.43 | -15.13 |
Asset Turnover | 0.55 | 0.55 | 0.55 | 0.55 | 0.58 | 0.61 |
Inventory Turnover | 1.92 | 1.92 | 2.31 | 2.37 | 2.31 | 2.34 |
Quick Ratio | 2.81 | 2.81 | 2.42 | 2.79 | 2.02 | 3.37 |
Current Ratio | 4.30 | 4.30 | 3.56 | 3.75 | 2.69 | 4.15 |
Return on Equity (ROE) | -1.83% | -1.83% | -3.42% | 0.38% | 2.74% | 3.27% |
Return on Assets (ROA) | -1.84% | -1.84% | -2.71% | -0.08% | 0.73% | 2.28% |
Return on Invested Capital (ROIC) | -4.15% | -4.18% | -6.20% | -0.07% | 1.21% | 3.88% |
Return on Capital Employed (ROCE) | -3.40% | -3.40% | -5.10% | -0.10% | 1.40% | 4.10% |
Earnings Yield | -2.29% | -2.58% | -4.79% | 0.43% | 2.62% | 2.99% |
FCF Yield | 2.04% | 2.30% | -1.36% | -18.85% | -7.47% | 1.83% |
Dividend Yield | 1.08% | - | - | 1.72% | 1.47% | 1.47% |
Payout Ratio | - | - | - | 355.21% | 49.17% | 41.43% |
Buyback Yield / Dilution | -0.59% | -0.59% | -0.53% | 0.11% | -1.62% | -4.30% |
Total Shareholder Return | 0.48% | -0.59% | -0.53% | 1.83% | -0.15% | -2.84% |